Kiropraktorhuset Slagelse ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  0.9% 1.1% 1.9% 1.1% 1.0%  
Credit score (0-100)  89 84 69 85 84  
Credit rating  A A A A A  
Credit limit (kDKK)  214.5 97.9 0.5 146.1 131.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  4,711 5,817 6,301 6,920 7,125  
EBITDA  1,248 346 83.3 902 742  
EBIT  1,182 295 2.7 829 693  
Pre-tax profit (PTP)  1,174.8 288.6 -2.1 822.6 690.7  
Net earnings  915.5 222.3 -3.0 639.2 534.4  
Pre-tax profit without non-rec. items  1,175 289 -2.1 823 691  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  436 726 848 774 1,014  
Shareholders equity total  1,436 1,058 455 1,094 829  
Interest-bearing liabilities  2.5 1.3 235 0.0 213  
Balance sheet total (assets)  2,286 1,826 1,270 1,862 1,643  

Net Debt  -838 -139 215 -583 52.8  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,711 5,817 6,301 6,920 7,125  
Gross profit growth  5.0% 23.5% 8.3% 9.8% 3.0%  
Employees  11 13 14 12 11  
Employee growth %  37.5% 18.2% 7.7% -14.3% -8.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,286 1,826 1,270 1,862 1,643  
Balance sheet change%  30.5% -20.1% -30.5% 46.7% -11.8%  
Added value  1,247.6 345.9 83.3 909.9 741.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -131 239 41 -146 191  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  25.1% 5.1% 0.0% 12.0% 9.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  58.6% 14.4% 0.2% 53.0% 39.7%  
ROI %  88.1% 23.1% 0.3% 89.2% 61.1%  
ROE %  71.6% 17.8% -0.4% 82.5% 55.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  62.8% 58.0% 35.9% 58.8% 50.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -67.2% -40.1% 258.3% -64.6% 7.1%  
Gearing %  0.2% 0.1% 51.7% 0.0% 25.7%  
Net interest  0 0 0 0 0  
Financing costs %  22.6% 341.6% 4.1% 5.7% 3.9%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.1 0.9 0.2 1.2 0.5  
Current Ratio  2.1 0.9 0.2 1.2 0.5  
Cash and cash equivalent  840.6 139.8 19.9 582.8 160.2  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  894.0 -47.0 -627.3 116.5 -367.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  113 27 6 76 67  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  113 27 6 75 67  
EBIT / employee  107 23 0 69 63  
Net earnings / employee  83 17 -0 53 49